Life Sciences Tools and Services
Company Overview of FlowMetric, Inc.
FlowMetric, Inc., a contract resource organization, provides polychromatic flow cytometry and immunohistochemistry services to biopharmaceutical and drug discovery companies. It offers flow cytometry services, including intracellular cytokines, cell surface markers/biomarkers, cell signaling proteins, phosphoproteins, cellular-antibody binding and multiplexed bead assays, screening and optimization of drug candidates, potency assays, pharmacokinetics, neutralizing antibodies, and antigen-specific T cell multimer analysis. The company also provides flow cytometry analysis that supports pre-clinical drug development, including immunophenotyping, peripheral blood cross-reactivity, binding activ...
3805 Old Easton Road
Pennsylvania Biotechnology Center of Bucks County
Doylestown, PA 18902
Founded in 2010
Key Executives for FlowMetric, Inc.
Founder, Chairman and Chief Executive Officer
President and Director of Human Resources
Director of Business Development
Compensation as of Fiscal Year 2015.
FlowMetric, Inc. Key Developments
FlowMetric, Inc. Appoints Floyd E. Fox as Chief Scientific Officer
Jun 9 15
FlowMetric, Inc. announced that they have appointed Floyd E. Fox, Ph.D. as Chief Scientific Officer. Dr. Fox will be responsible for leading FlowMetric’s research and development strategy and assuring all client support activities are carried out according the scientific and regulatory standards. Dr. Fox, an Immunologist by training, is an expert in the conception, development and implementation of innovative non-clinical and clinical bioanalytical methods aimed at understanding the mechanism of action of biotherapeutics. Dr. Fox has nearly 25 years’ experience in the areas of non-clinical and clinical pharmacology, immunogenicity, cytokine biology, infection and inflammation, oncology and immunology. Prior to joining FlowMetric, Dr. Fox served for nearly 15 years at Eli Lilly and Company (Imclone Systems) in roles of increasing responsibility as Director and Senior Director, culminating and Associate Vice-President, Clinical Pharmacology and Drug Disposition. Dr. Fox was instrumental in the US and global marketing approval of Erbitux and Cyramza.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries